Jeffrey Cook, MD
Interventional Cardiology · Quincy, ILNPI 1952353518
Payments from drug & device makers
Across 298 payments — averaging $67.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Edwards Lifesciences$3K
- Abbott$2K
- Shockwave Medical, Inc$381
- Boston Scientific$322
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$294
- plus $2K from 24 others
What the payments were for
- Travel & lodging$12,71563%
- Food & beverage$7,35337%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 104 | $12,107 |
| Edwards Lifesciences | 20 | $3,478 |
| Abbott | 49 | $1,907 |
| Shockwave Medical, Inc | 19 | $381 |
| Boston Scientific | 14 | $322 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $294 |
| Novartis | 11 | $233 |
| Abiomed | 5 | $212 |
| AstraZeneca | 11 | $160 |
| Recor Medical Inc | 1 | $118 |
| Penumbra, Inc. | 1 | $116 |
| Angiodynamics, Inc. | 4 | $93 |
| Amgen | 6 | $84 |
| Pfizer | 4 | $77 |
| Heartflow, Inc. | 3 | $54 |
| ZOLL Circulation Inc | 4 | $53 |
| Nobel Biocare USA | 1 | $49 |
| Livanova USA, Inc. | 1 | $47 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Johnson & Johnson | 3 | $40 |
| Teleflex LLC | 2 | $39 |
| Cardiva Medical, Inc. | 2 | $30 |
| Merck | 1 | $26 |
| Inari Medical, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Cardiovascular Systems Inc. | 1 | $17 |
| Philips North America LLC | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Venturemed Group, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$7,883
- Edwards SAPIEN 3 Transcatheter Heart Valve$2,534
- TRICLIP$898
- CoreValve Evolut$857
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$240
- Indigo$231
- ONYX FRONTIER$119
- Paradise Ultrasound Renal Denervation System$118
- Xience Sierra Coronary Stent System$114
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$106
- Impella$102
How this compares
$20,081 in reported general payments places this provider in the 65th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 280 | $295,847 |
| XareltoRivaroxaban | 99 | $109,238 |
| EntrestoSacubitril/Valsartan | 53 | $47,674 |
| MultaqDronedarone Hcl | 20 | $36,106 |
| Repatha SureclickEvolocumab | 46 | $35,733 |
| Praluent PenAlirocumab | 14 | $11,689 |
| Prasugrel Hcl | 56 | $7,896 |
| CorlanorIvabradine Hcl | 13 | $7,795 |
| JardianceEmpagliflozin | 11 | $7,357 |
| Ranolazine ErRanolazine | 30 | $5,788 |
| Metoprolol Succinate | 476 | $4,364 |
| ClopidogrelClopidogrel Bisulfate | 501 | $3,639 |
| Rosuvastatin Calcium | 146 | $3,512 |
| Potassium Chloride | 174 | $3,154 |
| Atorvastatin Calcium | 403 | $3,145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $77 | $295,847280 claims |
| Johnson & JohnsonXarelto | $40 | $109,23899 claims |
| NovartisEntresto | $233 | $47,67453 claims |
| AmgenCorlanor | $84 | $7,79513 claims |
| Boehringer IngelheimJardiance | $18 | $7,35711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Quincy
- Adam RafiQuincy$84K
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Mark RicciardiEvanston$2.2M
- Andrei PopElk Grove Village$1.9M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Justin LevisayEvanston$837K
- Atman ShahChicago$794K
- Laura DavidsonChicago$661K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.